Controlled Substance Market, By Drug Class, By Application, By Sales Channel, By Geography

PUBLISHED: November 7, 2023

PAGES: 175 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Global Controlled Substance Market size is expected to reach US$ 58.4 Bn by 2030, from US$ 41.8 Bn in 2023, by exhibiting a compounded annual growth rate (CAGR) of 4.9% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 41.8 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.90%	2030 Value Projection:	US$ 58.4 Bn

Figure 1. Global Controlled Substance Market Share (%), By Region, 2023

The global controlled substance market is a highly regulated and specialized sector within the pharmaceutical industry. Controlled substances are drugs that have the potential for abuse and dependence, and thus are therefore subject to strict government regulations. These substances are classified into different schedules based on their medical use, potential for abuse, and safety profile.

Market Dynamics:

The market dynamics of the global controlled substance market are influenced by various factors. The drivers of the market include the increasing prevalence of chronic diseases, rising demand for pain management drugs, and the growing geriatric population. On the other hand, the market is restrained by stringent government regulations, risk of drug abuse and addiction, and the high cost of research and development.

However, the market also presents opportunities for growth. The development of novel drug delivery systems, advancements in technology, and the increasing focus on personalized medicine are expected to drive market growth. The expansion of healthcare infrastructure in emerging economies and the growing awareness about mental health disorders are creating new avenues for market players.

The global controlled substance market is a highly regulated and specialized sector within the pharmaceutical industry. The market dynamics are influenced by various factors, including government regulations, market drivers, restraints, and opportunities. The key market players are focused on research and development, and distribution of controlled substances in order to meet the growing demand for pain management and chronic disease treatment.

Key features of the study:

This report provides in-depth analysis of the global controlled substance market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global controlled substance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi, Merck & Co., Inc., Gilead Sciences, Inc., Amgen Inc., Novartis Pharmaceuticals Corporation, AbbVie Inc., GSK Plc., AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Teva Pharmaceutical Inc., Bayer AG, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Aspen Holdings and Astellas Pharma Inc.
These companies are involved in the research, development, manufacturing, and distribution of controlled substances
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global controlled substance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global controlled substance market

Detailed Segmentation:

By Drug Class:
- Opioids
- Stimulants
- Depressants
- Hallucinogens
- Anabolic Steroids
- Others
By Application:
- Pain Management
- Anxiety
- Insomnia
- Cough Suppression
- ADHD
- Narcolepsy
- Others
By Distribution Channel:
- Hospitals & Clinics
- Pharmacies
- Others (Academic & Research Institutes, etc.)
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in Global Controlled Substance Market
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Sanofi
- Merck & Co., Inc.
- Gilead Sciences, Inc.
- Amgen Inc.
- Novartis Pharmaceuticals Corporation
- AbbVie Inc.
- GSK Plc.
- AstraZeneca
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Teva Pharmaceutical Inc.
- Bayer AG
- Novo Nordisk A/S
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
- Aspen Holdings
- Astellas Pharma Inc.

Product Code: CMI6201

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Sales Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Controlled Substance Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Controlled Substance Market, By Drug Class, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Stimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Depressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Hallucinogens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Anabolic Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Controlled Substance Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Anxiety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Insomnia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Attention Deficit Hyperactivity Disorder (ADHD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Narcolepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Controlled Substance Market, By Sales Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others (Academic & Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Controlled Substance Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region , 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Company Profile
- Johnson & Johnson Services, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Pfizer Inc.
- Sanofi
- Merck & Co., Inc.
- Gilead Sciences, Inc.
- Amgen Inc.
- Novartis Pharmaceuticals Corporation
- AbbVie Inc.
- GSK Plc.
- AstraZeneca
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Teva Pharmaceutical Inc.
- Bayer AG
- Novo Nordisk A/S
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
- Aspen Holdings
- Astellas Pharma Inc.
- Analysts' Views